Stay updated on Pembrolizumab & Radiation for Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation for Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record for the pembrolizumab and external-beam-radiation trial in relapsed or refractory non-Hodgkin lymphoma is displayed with its study details, outcomes, eligibility criteria, and record dates. It also includes links to the protocol and informed consent form and indicates that the study is completed and no longer seeking participants.SummaryDifference57%

- Check20 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 Forbidden message.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check34 days agoChange DetectedThe footer site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check41 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 error page, with its displayed site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now renders a 403 Forbidden error page, with standard HTML headers and a 403 message, instead of showing the study details. This reflects an access restriction rather than substantive content changes to the study record.SummaryDifference19%

Stay in the know with updates to Pembrolizumab & Radiation for Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation for Lymphoma Clinical Trial page.